Xspray Pharma AB (publ) (XSPRAY.ST)
SEK 41.5
(-5.36%)
SEK 41.5
(-5.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -203.27 Million | -110.17 Million | -51.6 Million | -47.79 Million | -34.23 Million | -17.74 Million |
| Net Income | -179.66 Million | -133.07 Million | -97.95 Million | -53.45 Million | -46.56 Million | -23.21 Million |
| Depreciation & Amortization | 9.19 Million | 9.53 Million | 8.87 Million | 7.68 Million | 4.8 Million | 4.1 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -31.58 Million | -3.57 Million | 4.37 Million | -1.31 Million | 8.89 Million | 1.25 Million |
| Other non-cash items | -1.22 Million | 16.93 Million | 33.1 Million | -709 Thousand | -1.37 Million | 119 Thousand |
| Investing Cash Flow | -65.87 Million | -135.34 Million | -105.81 Million | -96.82 Million | -91.99 Million | -47 Million |
| Investments in PPE | -54.1 Million | -128.28 Million | -95.96 Million | -97.21 Million | -91.99 Million | -46.95 Million |
| Acquisitions | - | - | - | 383 Thousand | - | - |
| Investment purchases | - | - | - | - | - | -50 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -11.77 Million | -7.05 Million | -9.85 Million | -3.65 Million | -68.89 Thousand | -32.01 Million |
| Financing Cash Flow | 315.59 Million | 93.8 Million | 103.7 Million | 260.34 Million | 114.83 Million | 170.45 Million |
| Debt repayment | -45 Million | -2.12 Million | -2.15 Million | -936 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -52 Thousand | -54 Thousand | -74 Thousand | - | - |
| Common Stock Issuance | 272.24 Million | 100.81 Million | 105.91 Million | 261.54 Million | 114.94 Million | 170.45 Million |
| Other Financing Activities | 88.34 Million | -2.64 Million | 105.86 Million | 821 Thousand | -112 Thousand | 170.45 Million |
| Accounts receivables | -4.1 Million | -2.94 Million | -5.71 Million | 2.47 Million | -1.96 Million | -3.76 Million |
| Accounts payables | 7.75 Million | -633 Thousand | 10.08 Million | -3.79 Million | 10.85 Million | 4.89 Million |
| Inventory | -35.22 Million | 633.00 | -10.08 Thousand | 3794.00 | -10.85 Thousand | - |
| Other working capital | 7757.00 | -633.00 | 10.08 Thousand | -3794.00 | 10.85 Thousand | 126 Thousand |
| Cash at beginning of period | 120.16 Million | 271.88 Million | 325.59 Million | 209.87 Million | 221.26 Million | 115.51 Million |
| Cash at end of period | 166.3 Million | 120.16 Million | 271.88 Million | 325.59 Million | 209.87 Million | 221.21 Million |
| Capital Expenditure | -54.1 Million | -128.28 Million | -95.96 Million | -97.21 Million | -91.99 Million | -46.95 Million |
| Effect of forex changes on cash | -306 Thousand | - | - | 1000.00 | - | - |
| Net cash flow / Change in cash | 46.13 Million | -151.71 Million | -53.71 Million | 115.72 Million | -11.39 Million | 105.7 Million |
| Free Cash Flow | -257.37 Million | -238.46 Million | -147.57 Million | -145 Million | -126.23 Million | -64.7 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -53.58 Million | -67.74 Million | -179.66 Million | -54.49 Million | -39.23 Million | -51.26 Million |
| Depreciation & Amortization | 2.34 Million | 2.7 Million | 9.19 Million | 2.44 Million | 2.23 Million | 2.23 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -11.83 Million | 10.67 Million | -31.58 Million | 20.02 Million | -31.17 Million | -7.74 Million |
| Other non-cash items | 15.42 Million | -6.22 Million | -1.22 Million | -606.99 Thousand | -426 Thousand | 2.49 Million |
| Investing Cash Flow | -8.73 Million | -5.14 Million | -65.87 Million | -20.72 Million | -14.47 Million | -16.02 Million |
| Investments in PPE | -8.73 Million | -5.14 Million | -54.1 Million | -16.93 Million | -8.62 Million | -14.92 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -4.42 Million | -5.08 Million | -11.77 Million | -3.79 Million | -5.84 Million | -1.1 Million |
| Financing Cash Flow | 95.32 Million | -1.82 Million | 315.59 Million | 87.48 Million | 184.01 Million | 44.67 Million |
| Debt repayment | -1.19 Million | -1.22 Million | -45 Million | -193.00 | -280 Thousand | -592 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 64 Thousand | -64 Thousand | - | - | - | - |
| Common Stock Issuance | 96.51 Million | -538 Thousand | 272.24 Million | 87.67 Million | 205.63 Million | 522 Thousand |
| Other Financing Activities | 96.51 Million | -602 Thousand | 88.34 Million | -193 Thousand | -21.33 Million | 44.74 Million |
| Accounts receivables | 834 Thousand | 694 Thousand | -4.1 Million | 27.98 Million | 5.59 Million | -27.16 Million |
| Accounts payables | -11.76 Million | 9.8 Million | 7.75 Million | -7.17 Million | -2.31 Million | 19.42 Million |
| Inventory | -905 Thousand | 179 Thousand | -35.22 Million | -778 Thousand | 2.28 Million | -19.42 Thousand |
| Other working capital | -11.76 Million | 9.8 Million | 7757.00 | -7176.00 | -36.73 Million | 19.42 Thousand |
| Cash at beginning of period | 104.15 Million | 166.3 Million | 120.16 Million | 132.47 Million | 31.54 Million | 59.39 Million |
| Cash at end of period | 126.57 Million | 104.15 Million | 166.3 Million | 166.3 Million | 132.48 Million | 31.54 Million |
| Capital Expenditure | -8.73 Million | -5.14 Million | -54.1 Million | -16.93 Million | -8.62 Million | -14.92 Million |
| Effect of forex changes on cash | 14 Thousand | 136 Thousand | -306 Thousand | -306 Thousand | - | - |
| Net cash flow / Change in cash | 22.41 Million | -62.14 Million | 46.13 Million | 33.82 Million | 100.93 Million | -27.85 Million |
| Free Cash Flow | -72.91 Million | -60.46 Million | -257.37 Million | -49.55 Million | -77.23 Million | -71.42 Million |
AWX
0R0P
BRNHF
2158
8331
0ID1